NCT00040092View on ClinicalTrials.gov

A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2005

Conditions
Pancreatic Cancer
Interventions
DRUG

Virulizin®

Sponsors
All Listed Sponsors
lead

Aptose Biosciences Inc.

INDUSTRY